| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid binding | 6.89e-07 | 28 | 122 | 5 | GO:0001972 | |
| GeneOntologyMolecularFunction | lipid binding | CYP26B1 CETP UGT1A10 UGT1A8 UGT1A7 SNX17 GSDMB UGT1A9 DNM1L MYO1B GCDH DYSF TRIP10 INPP4B SLC9A1 TLN1 PITPNM3 SYT4 TRPV4 SNX5 | 2.22e-06 | 988 | 122 | 20 | GO:0008289 |
| GeneOntologyMolecularFunction | retinoid binding | 1.09e-05 | 48 | 122 | 5 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 1.21e-05 | 49 | 122 | 5 | GO:0019840 | |
| GeneOntologyMolecularFunction | N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity | 3.70e-05 | 2 | 122 | 2 | GO:0003948 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 5.20e-05 | 66 | 122 | 5 | GO:0005080 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 6.00e-05 | 35 | 122 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC1 ATP7A DNAH10 ERCC6L KIF1B DNAH2 DNM1L MCM7 XRCC5 ARL4C ATP2C1 ABCE1 KIF13A GFM1 AGAP2 | 7.73e-05 | 775 | 122 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC1 ATP7A DNAH10 ERCC6L KIF1B DNAH2 MCM7 XRCC5 ATP2C1 ABCE1 KIF13A | 8.38e-05 | 441 | 122 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | TTF2 ABCC1 ATP7A DNAH10 ERCC6L KIF1B DNAH2 MYO1B MCM7 XRCC5 ATP2C1 ABCE1 KIF13A | 9.88e-05 | 614 | 122 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCC1 ATP7A DNAH10 ERCC6L KIF1B DNAH2 DNM1L MCM7 XRCC5 ARL4C ATP2C1 ABCE1 KIF13A GFM1 AGAP2 | 1.85e-04 | 839 | 122 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCC1 ATP7A DNAH10 ERCC6L KIF1B DNAH2 DNM1L MCM7 XRCC5 ARL4C ATP2C1 ABCE1 KIF13A GFM1 AGAP2 | 1.87e-04 | 840 | 122 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCC1 ATP7A DNAH10 ERCC6L KIF1B DNAH2 DNM1L MCM7 XRCC5 ARL4C ATP2C1 ABCE1 KIF13A GFM1 AGAP2 | 1.87e-04 | 840 | 122 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRB2 ABCC1 ATP7A SLC26A9 GRIK3 NDUFS1 RYR3 SLC22A6 SLC9A1 ATP2C1 TRPV4 CACNA1H UQCRH UQCRHL | 2.21e-04 | 758 | 122 | 14 | GO:0015318 |
| GeneOntologyMolecularFunction | protein homodimerization activity | RAG1 PDK2 UGT1A10 UGT1A8 UGT1A7 AOX1 UGT1A9 DNM1L ALS2 ACTN4 THRA CARD9 ANKRD11 SYT4 | 4.58e-04 | 815 | 122 | 14 | GO:0042803 |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 5.07e-04 | 107 | 122 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 7.91e-04 | 118 | 122 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 7.94e-04 | 178 | 122 | 6 | GO:0015399 | |
| GeneOntologyMolecularFunction | fatty acid binding | 8.44e-04 | 69 | 122 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 8.91e-04 | 70 | 122 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | ubiquinol-cytochrome-c reductase activity | 1.01e-03 | 8 | 122 | 2 | GO:0008121 | |
| GeneOntologyMolecularFunction | steroid binding | 1.35e-03 | 133 | 122 | 5 | GO:0005496 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.90e-03 | 211 | 122 | 6 | GO:0016758 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on diphenols and related substances as donors | 1.96e-03 | 11 | 122 | 2 | GO:0016679 | |
| GeneOntologyMolecularFunction | nucleoside binding | 1.96e-03 | 11 | 122 | 2 | GO:0001882 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 5.80e-09 | 5 | 122 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 1.73e-08 | 6 | 122 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 1.73e-08 | 6 | 122 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 1.73e-08 | 6 | 122 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 2.38e-07 | 10 | 122 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 2.38e-07 | 10 | 122 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 7.99e-07 | 13 | 122 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.62e-06 | 34 | 122 | 5 | GO:0006706 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 2.00e-06 | 5 | 122 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 6.45e-06 | 21 | 122 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 6.45e-06 | 21 | 122 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.57e-05 | 26 | 122 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.57e-05 | 26 | 122 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 2.01e-05 | 94 | 122 | 6 | GO:0042440 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 2.09e-05 | 141 | 122 | 7 | GO:0006805 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 4.27e-05 | 12 | 122 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | dense core granule cytoskeletal transport | 4.27e-05 | 12 | 122 | 3 | GO:0099519 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 4.80e-05 | 67 | 122 | 5 | GO:0019748 | |
| GeneOntologyBiologicalProcess | vesicle cytoskeletal trafficking | 4.80e-05 | 67 | 122 | 5 | GO:0099518 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 5.34e-05 | 222 | 122 | 8 | GO:0071466 | |
| GeneOntologyBiologicalProcess | dense core granule transport | 7.01e-05 | 14 | 122 | 3 | GO:1901950 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 9.03e-05 | 40 | 122 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 2.53e-04 | 52 | 122 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | macrophage activation involved in immune response | 2.86e-04 | 22 | 122 | 3 | GO:0002281 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | CYP26B1 CETP UGT1A10 UGT1A8 UGT1A7 SNX17 UGT1A9 MECP2 CACNA1H | 4.03e-04 | 376 | 122 | 9 | GO:0008202 |
| GeneOntologyBiologicalProcess | lipid catabolic process | 4.52e-04 | 382 | 122 | 9 | GO:0016042 | |
| Domain | UDPGT | 9.52e-06 | 21 | 122 | 4 | PF00201 | |
| Domain | UDPGT | 9.52e-06 | 21 | 122 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 9.52e-06 | 21 | 122 | 4 | IPR002213 | |
| Domain | - | 4.23e-05 | 2 | 122 | 2 | 1.20.1420.10 | |
| Domain | VBS | 4.23e-05 | 2 | 122 | 2 | PF08913 | |
| Domain | Vinculin-bd_dom | 4.23e-05 | 2 | 122 | 2 | IPR015009 | |
| Domain | UCR_hinge | 4.23e-05 | 2 | 122 | 2 | PF02320 | |
| Domain | Talin_cent | 4.23e-05 | 2 | 122 | 2 | IPR015224 | |
| Domain | Cyt_b-c1_6 | 4.23e-05 | 2 | 122 | 2 | IPR003422 | |
| Domain | Talin_middle | 4.23e-05 | 2 | 122 | 2 | PF09141 | |
| Domain | Ubol_cytC_Rdtase_hinge_dom | 4.23e-05 | 2 | 122 | 2 | IPR023184 | |
| Domain | - | 4.23e-05 | 2 | 122 | 2 | 1.10.287.20 | |
| Domain | Peptidase_T2 | 1.26e-04 | 3 | 122 | 2 | IPR000246 | |
| Domain | Talin-1 | 1.26e-04 | 3 | 122 | 2 | IPR015710 | |
| Domain | Asparaginase_2 | 1.26e-04 | 3 | 122 | 2 | PF01112 | |
| Domain | Kinesin-like_KIF1-typ | 2.52e-04 | 4 | 122 | 2 | IPR022140 | |
| Domain | ILWEQ_dom | 2.52e-04 | 4 | 122 | 2 | IPR002558 | |
| Domain | ILWEQ | 2.52e-04 | 4 | 122 | 2 | SM00307 | |
| Domain | KIF1B | 2.52e-04 | 4 | 122 | 2 | PF12423 | |
| Domain | FERM_f0 | 2.52e-04 | 4 | 122 | 2 | PF16511 | |
| Domain | ILWEQ | 2.52e-04 | 4 | 122 | 2 | PD011820 | |
| Domain | - | 2.52e-04 | 4 | 122 | 2 | 1.20.1410.10 | |
| Domain | I_LWEQ | 2.52e-04 | 4 | 122 | 2 | PF01608 | |
| Domain | I_LWEQ | 2.52e-04 | 4 | 122 | 2 | PS50945 | |
| Domain | FERM_f0 | 2.52e-04 | 4 | 122 | 2 | IPR032425 | |
| Domain | 2Fe2S_fd_BS | 4.18e-04 | 5 | 122 | 2 | IPR006058 | |
| Domain | 2FE2S_FER_1 | 4.18e-04 | 5 | 122 | 2 | PS00197 | |
| Domain | P-loop_NTPase | TTF2 ABCC1 DNAH10 ERCC6L KIF1B DNAH2 DNM1L MYO1B MCM7 ARL4C ABCE1 UCKL1 KIF13A GFM1 AGAP2 | 4.21e-04 | 848 | 122 | 15 | IPR027417 |
| Domain | Kinesin_assoc | 6.24e-04 | 6 | 122 | 2 | PF16183 | |
| Domain | 2FE2S_FER_2 | 6.24e-04 | 6 | 122 | 2 | PS51085 | |
| Domain | 2Fe-2S_ferredoxin-type | 6.24e-04 | 6 | 122 | 2 | IPR001041 | |
| Domain | Kinesin-like | 6.24e-04 | 6 | 122 | 2 | IPR022164 | |
| Domain | Fer2 | 6.24e-04 | 6 | 122 | 2 | PF00111 | |
| Domain | Kinesin_assoc | 6.24e-04 | 6 | 122 | 2 | IPR032405 | |
| Domain | DUF3694 | 6.24e-04 | 6 | 122 | 2 | PF12473 | |
| Domain | Vinculin/catenin | 8.70e-04 | 7 | 122 | 2 | IPR006077 | |
| Domain | DHC_N1 | 1.15e-03 | 8 | 122 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.15e-03 | 8 | 122 | 2 | IPR013594 | |
| Domain | - | 1.84e-03 | 10 | 122 | 2 | 3.40.47.10 | |
| Domain | Thiolase-like | 1.84e-03 | 10 | 122 | 2 | IPR016039 | |
| Domain | PH_dom-like | 1.94e-03 | 426 | 122 | 9 | IPR011993 | |
| Domain | AAA | 2.56e-03 | 144 | 122 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 2.56e-03 | 144 | 122 | 5 | IPR003593 | |
| Domain | - | TTF2 ABCC1 DNAH10 ERCC6L DNAH2 DNM1L MCM7 ARL4C ABCE1 UCKL1 GFM1 AGAP2 | 3.54e-03 | 746 | 122 | 12 | 3.40.50.300 |
| Domain | Dynein_heavy_chain_D4_dom | 3.66e-03 | 14 | 122 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.66e-03 | 14 | 122 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.66e-03 | 14 | 122 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.66e-03 | 14 | 122 | 2 | PF08393 | |
| Domain | - | 3.66e-03 | 14 | 122 | 2 | 3.10.20.30 | |
| Domain | ATPase_dyneun-rel_AAA | 3.66e-03 | 14 | 122 | 2 | IPR011704 | |
| Domain | IRS | 3.66e-03 | 14 | 122 | 2 | PF02174 | |
| Domain | IRS_PTB | 3.66e-03 | 14 | 122 | 2 | IPR002404 | |
| Domain | Beta-grasp_dom | 3.66e-03 | 14 | 122 | 2 | IPR012675 | |
| Domain | MT | 3.66e-03 | 14 | 122 | 2 | PF12777 | |
| Domain | AAA_8 | 3.66e-03 | 14 | 122 | 2 | PF12780 | |
| Domain | AAA_5 | 3.66e-03 | 14 | 122 | 2 | PF07728 | |
| Domain | - | 4.17e-03 | 391 | 122 | 8 | 2.30.29.30 | |
| Domain | DHC_fam | 4.20e-03 | 15 | 122 | 2 | IPR026983 | |
| Domain | MORN | 4.20e-03 | 15 | 122 | 2 | IPR003409 | |
| Domain | Dynein_heavy | 4.20e-03 | 15 | 122 | 2 | PF03028 | |
| Domain | MORN | 4.20e-03 | 15 | 122 | 2 | PF02493 | |
| Domain | Dynein_heavy_dom | 4.20e-03 | 15 | 122 | 2 | IPR004273 | |
| Domain | TPR_REGION | 4.58e-03 | 165 | 122 | 5 | PS50293 | |
| Domain | TPR | 4.58e-03 | 165 | 122 | 5 | PS50005 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 6.65e-06 | 39 | 97 | 5 | MM15695 | |
| Pathway | WP_ESTROGEN_METABOLISM | 1.40e-05 | 22 | 97 | 4 | MM15888 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.01e-05 | 24 | 97 | 4 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.38e-05 | 25 | 97 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 2.38e-05 | 25 | 97 | 4 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 2.38e-05 | 25 | 97 | 4 | M605 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 2.54e-05 | 51 | 97 | 5 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 2.80e-05 | 52 | 97 | 5 | M14171 | |
| Pathway | WP_GLUCURONIDATION | 2.80e-05 | 26 | 97 | 4 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 3.80e-05 | 28 | 97 | 4 | M19580 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 6.64e-05 | 12 | 97 | 3 | M39611 | |
| Pathway | KEGG_RETINOL_METABOLISM | 7.69e-05 | 64 | 97 | 5 | M9488 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 1.09e-04 | 14 | 97 | 3 | M39328 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.35e-04 | 72 | 97 | 5 | M9257 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.75e-04 | 41 | 97 | 4 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.53e-04 | 45 | 97 | 4 | MM15694 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 4.62e-04 | 5 | 97 | 2 | MM15582 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 5.49e-04 | 55 | 97 | 4 | M14933 | |
| Pathway | WP_NICOTINE_METABOLISM_IN_LIVER_CELLS | 6.90e-04 | 6 | 97 | 2 | M39600 | |
| Pubmed | 2.37e-09 | 6 | 125 | 4 | 32527940 | ||
| Pubmed | 2.37e-09 | 6 | 125 | 4 | 20297805 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 5.52e-09 | 7 | 125 | 4 | 8467709 | |
| Pubmed | 5.52e-09 | 7 | 125 | 4 | 8464825 | ||
| Pubmed | 5.52e-09 | 7 | 125 | 4 | 27514509 | ||
| Pubmed | 1.10e-08 | 8 | 125 | 4 | 20610558 | ||
| Pubmed | 1.10e-08 | 8 | 125 | 4 | 18052087 | ||
| Pubmed | 1.10e-08 | 8 | 125 | 4 | 17179145 | ||
| Pubmed | 1.98e-08 | 9 | 125 | 4 | 22511988 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 2.23e-08 | 24 | 125 | 5 | 24625756 | |
| Pubmed | 3.28e-08 | 10 | 125 | 4 | 23642732 | ||
| Pubmed | 3.28e-08 | 10 | 125 | 4 | 11465080 | ||
| Pubmed | 3.28e-08 | 10 | 125 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 3.28e-08 | 10 | 125 | 4 | 22558097 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 12847094 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 29519853 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | ABCC1 UGT1A10 UGT1A8 UGT1A7 TTC21A UGT1A9 MCM7 ACTN4 TRIP10 MECP2 NDUFS1 F13A1 C1GALT1C1 FASN AGA TLN1 HADHB SCFD1 UQCRH GFM1 UQCRHL | 5.22e-08 | 1451 | 125 | 21 | 30550785 |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 7.70e-08 | 12 | 125 | 4 | 20308471 | |
| Pubmed | 7.70e-08 | 12 | 125 | 4 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 7.70e-08 | 12 | 125 | 4 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 1.11e-07 | 13 | 125 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 1.11e-07 | 13 | 125 | 4 | 25246029 | |
| Pubmed | 1.55e-07 | 14 | 125 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 1.55e-07 | 14 | 125 | 4 | 10836148 | |
| Pubmed | 1.55e-07 | 14 | 125 | 4 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 1.55e-07 | 14 | 125 | 4 | 14672974 | |
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 17558305 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 2.80e-07 | 16 | 125 | 4 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 3.65e-07 | 17 | 125 | 4 | 20639394 | |
| Pubmed | 4.51e-07 | 5 | 125 | 3 | 20565459 | ||
| Pubmed | 4.51e-07 | 5 | 125 | 3 | 15057901 | ||
| Pubmed | 4.67e-07 | 190 | 125 | 8 | 24816252 | ||
| Pubmed | 4.68e-07 | 18 | 125 | 4 | 20056724 | ||
| Pubmed | ERCC6L DNM1L MCM7 ACTN4 XRCC5 THOC2 NDUFS1 FASN COQ8A TLN1 HADHB SCFD1 PPP6R3 | 5.53e-07 | 638 | 125 | 13 | 33239621 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 5.91e-07 | 19 | 125 | 4 | 23281178 | |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | 7.70e-07 | 203 | 125 | 8 | 16916647 | |
| Pubmed | BDP1 CASP8AP2 ASRGL1 ATP7A CDHR2 UNC5B KIF1B GSDMB DNM1L ALS2 ACTN4 XRCC5 TTF1 F13A1 INPP4B UQCRH CDC27 PPP6R3 | 9.10e-07 | 1293 | 125 | 18 | 15342556 | |
| Pubmed | TTF2 KIF1B ARHGAP17 DNM1L ACTN4 XRCC5 THOC2 SKP1 MRPS22 FASN ABCE1 HADHB CDC27 ALPK2 | 1.37e-06 | 809 | 125 | 14 | 32129710 | |
| Pubmed | TTF2 HAUS6 ATP7A ERCC6L UNC5B KIF1B DNM1L MYO1B XRCC5 FASN ABCE1 TLN1 CDC27 | 1.75e-06 | 708 | 125 | 13 | 39231216 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | TTF2 MYO1B GCDH MCM7 XRCC5 THOC2 SKP1 NDUFS1 FASN NMI COQ8A ABCE1 POLR1B HADHB CDC27 GFM1 PPP6R3 | 2.78e-06 | 1257 | 125 | 17 | 37317656 |
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 3.75e-06 | 9 | 125 | 3 | 20732626 | |
| Pubmed | 4.15e-06 | 66 | 125 | 5 | 19898482 | ||
| Pubmed | 7.32e-06 | 11 | 125 | 3 | 18695635 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TTF2 PDCD2 SNX17 MYO1B MCM7 ACTN4 XRCC5 SKP1 NDUFS1 FASN WASHC5 ABCE1 TLN1 POLR1B HADHB SCFD1 CDC27 | 7.33e-06 | 1353 | 125 | 17 | 29467282 |
| Pubmed | Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. | 9.74e-06 | 12 | 125 | 3 | 19349540 | |
| Pubmed | ZNF609 KIF1B MYO1B MCM7 ACTN4 XRCC5 THOC2 SKP1 NDUFS1 MRPS22 FASN ABCE1 WDR87 TLN1 HADHB PPP6R3 | 1.08e-05 | 1247 | 125 | 16 | 27684187 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.19e-05 | 211 | 125 | 7 | 24097068 | |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 1.19e-05 | 211 | 125 | 7 | 17314511 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 36565314 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 33971182 | ||
| Pubmed | The retinoic acid-metabolizing enzyme Cyp26b1 regulates CD4 T cell differentiation and function. | 1.28e-05 | 2 | 125 | 2 | 23991089 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 27421705 | ||
| Pubmed | Thyroid hormone receptor alpha 1 regulates expression of the Na+/H+ exchanger (NHE1). | 1.28e-05 | 2 | 125 | 2 | 12039959 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 11677206 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 21782149 | ||
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 1.28e-05 | 2 | 125 | 2 | 10497143 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12944498 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17529886 | ||
| Pubmed | Influenza A induces dysfunctional immunity and death in MeCP2-overexpressing mice. | 1.28e-05 | 2 | 125 | 2 | 28138553 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19820693 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 26822056 | ||
| Pubmed | Extracellular rigidity sensing by talin isoform-specific mechanical linkages. | 1.28e-05 | 2 | 125 | 2 | 26523364 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 21460185 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 25547628 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 32941650 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 11901093 | ||
| Pubmed | Deletion of Ku80 causes early aging independent of chronic inflammation and Rag-1-induced DSBs. | 1.28e-05 | 2 | 125 | 2 | 17928034 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22031623 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18568343 | ||
| Pubmed | Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. | 1.28e-05 | 2 | 125 | 2 | 17603215 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 15709193 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22306379 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 8706131 | ||
| Pubmed | Characterising a homozygous two-exon deletion in UQCRH: comparing human and mouse phenotypes. | 1.28e-05 | 2 | 125 | 2 | 34750991 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 9647757 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 20089735 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DNAH10 DNM1L MYO1B LAMC3 MCM7 ACTN4 XRCC5 THOC2 NDUFS1 FASN ABCE1 TLN1 TLN2 HADHB SCFD1 GFM1 MGAM2 | 1.43e-05 | 1425 | 125 | 17 | 30948266 |
| Pubmed | GABRB2 ASRGL1 STXBP5L PDK2 ACTN4 SKP1 NDUFS1 ATP2C1 WASHC5 ABCE1 PITPNM3 TLN2 HADHB GFM1 AGAP2 | 1.53e-05 | 1139 | 125 | 15 | 36417873 | |
| Pubmed | ABCC1 MYO1B GCDH MCM7 XRCC5 THOC2 SKP1 NDUFS1 MRPS22 FASN COQ8A TLN1 HSH2D HADHB SCFD1 UQCRH PPP6R3 | 1.64e-05 | 1440 | 125 | 17 | 30833792 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | GABRB2 PDCD2 CDHR2 CETP AOX1 MYO1B DYSF TRIP10 SCRN2 SLC22A6 FASN TREH TLN1 CCDC180 | 1.83e-05 | 1016 | 125 | 14 | 19056867 |
| Pubmed | ABCC1 MYO1B XRCC5 MRPS22 TFDP2 ATP2C1 TLN1 HADHB CDC27 PPP6R3 SNX5 | 1.92e-05 | 634 | 125 | 11 | 34591612 | |
| Pubmed | 2.45e-05 | 534 | 125 | 10 | 35032548 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | ABCC1 DNM1L LAMC3 THOC2 NDUFS1 MRPS22 TFDP2 SLC9A1 ATP2C1 TLN1 POLR1B SCFD1 KIF13A | 3.02e-05 | 925 | 125 | 13 | 28986522 |
| Pubmed | 3.56e-05 | 446 | 125 | 9 | 24255178 | ||
| Pubmed | Mitochondrial protein interactome elucidated by chemical cross-linking mass spectrometry. | 3.57e-05 | 343 | 125 | 8 | 28130547 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TTF2 ABCC1 ERCC6L DNAH2 GCDH FASN ATP2C1 TLN1 HADHB SCFD1 UQCRH TARBP1 PPP6R3 | 3.64e-05 | 942 | 125 | 13 | 31073040 |
| Pubmed | 3.66e-05 | 560 | 125 | 10 | 35241646 | ||
| Pubmed | Type I gamma phosphatidylinositol phosphate kinase targets and regulates focal adhesions. | 3.84e-05 | 3 | 125 | 2 | 12422220 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 37506502 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 16636344 | ||
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 3.84e-05 | 3 | 125 | 2 | 20007669 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 19244109 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 19225446 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 22445450 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 17406868 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 18792400 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 22665520 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 19996319 | ||
| Pubmed | An essential role for talin during alpha(M)beta(2)-mediated phagocytosis. | 3.84e-05 | 3 | 125 | 2 | 17202407 | |
| Pubmed | DNA-Mediated Gene Therapy in a Mouse Model of Limb Girdle Muscular Dystrophy 2B. | 3.84e-05 | 3 | 125 | 2 | 29159199 | |
| Interaction | SRC interactions | PDCD2 UGT1A7 SNX17 ARHGAP17 MCM7 ACTN4 TRIP10 MRPS22 THRA GUCY2C ABCE1 TLN1 ANKRD11 TRPV4 CCDC180 AGAP2 | 3.22e-06 | 664 | 124 | 16 | int:SRC |
| Cytoband | 2q37 | 1.56e-06 | 31 | 125 | 4 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 4.02e-04 | 226 | 125 | 5 | chr2q37 | |
| GeneFamily | UDP glucuronosyltransferases | 1.86e-05 | 32 | 90 | 4 | 363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-09 | 184 | 125 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-09 | 184 | 125 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-09 | 184 | 125 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.73e-07 | 176 | 125 | 7 | a9e77681bcd36c382d53eb6f771349d55f98d744 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-06 | 197 | 125 | 7 | b6689a3e01e4c285fc2cb33f8c437078722a3892 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.48e-06 | 198 | 125 | 7 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.53e-06 | 199 | 125 | 7 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.53e-06 | 199 | 125 | 7 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | Adult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.89e-06 | 154 | 125 | 6 | 38d346402417960044ae999e61f0092b46f2b591 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.88e-06 | 159 | 125 | 6 | d3f81ba22160568ccaa6d2b04ebfd30630f9a6db | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.09e-06 | 160 | 125 | 6 | 6b0faaa371650563f585722f5b2fb319e124ec38 | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT2|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.52e-06 | 173 | 125 | 6 | f6e36ea98a9c669ff393d141455aaecef083f738 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.52e-06 | 173 | 125 | 6 | afa6bb19df52541d8d17cbfac9cbdd18a5f3632d | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-05 | 177 | 125 | 6 | d6596a0b6fd146fefc27717c1a7dbaa3774cc644 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 179 | 125 | 6 | dfd5b25f2a6a5a8bf4714f1516cb0997de72b06f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 183 | 125 | 6 | 85446581999cd66b171c4f69b7eb8b0bbbaa8617 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 185 | 125 | 6 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-05 | 189 | 125 | 6 | a34f008dfcee4012977bbc5b60de6f0329ca2f65 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 1.88e-05 | 195 | 125 | 6 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 196 | 125 | 6 | e224338490691d92c1f70b57112fabdcc92b06a9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 197 | 125 | 6 | c10dd1aaec01fb662eac83dfde90e3e426665d65 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 197 | 125 | 6 | 2844dbcd0a673ed81c99920aa45858651a00736d | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-05 | 198 | 125 | 6 | ff8a9adc1302a4679ccdfe9ef95ef53e4c7a5391 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-05 | 198 | 125 | 6 | 09e452742aed9f48bf1ffc35c6b06a296bcfe076 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.04e-05 | 198 | 125 | 6 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.10e-05 | 199 | 125 | 6 | fd3706f256e33cf348774bea0ba0df6d41fd96e3 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.10e-05 | 199 | 125 | 6 | 252f0084fa17770f4c34e21066519d7f7cad75d9 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.10e-05 | 199 | 125 | 6 | e981b159841222a6838effff1059c683c20ecf5b | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.10e-05 | 199 | 125 | 6 | 8cdd5aa30a8112b77f5d02b40c45b63f541e1476 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-NK|COVID-19_Convalescent / Disease group, lineage and cell class | 2.10e-05 | 199 | 125 | 6 | 9809d996a2c3f5384707646a3929e1d6b85dcdc2 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.10e-05 | 199 | 125 | 6 | a2ac6af5e8e13e7edd3302ebdb175a3902bfb2bc | |
| ToppCell | remission-NK|remission / disease stage, cell group and cell class | 2.10e-05 | 199 | 125 | 6 | 31ed2a314e8f70980ea0686242446d66929288e9 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-NK_CD56bright|IIF / Disease, condition lineage and cell class | 2.10e-05 | 199 | 125 | 6 | 9eb2b7d4900b118338590db778a47504559e228d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.10e-05 | 199 | 125 | 6 | 899642ff6bb6c1612f14a9a049b4344ae694752a | |
| ToppCell | Control-NK|Control / Disease condition and Cell class | 2.10e-05 | 199 | 125 | 6 | f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-NK|COVID-19_Convalescent / Disease, condition lineage and cell class | 2.16e-05 | 200 | 125 | 6 | 50d844683dcfe35e59fffa0c23f1532d692d0c17 | |
| ToppCell | COVID-19_Convalescent-NK|COVID-19_Convalescent / Disease condition and Cell class | 2.16e-05 | 200 | 125 | 6 | dd62477b12c54065d4b70866c1523e9c217a48a9 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Cycling_mono|Lung / Manually curated celltypes from each tissue | 7.88e-05 | 156 | 125 | 5 | 63b8cf14361b282872bc1c5b65d9fbc83e81a089 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 7.88e-05 | 156 | 125 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.70e-05 | 163 | 125 | 5 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.70e-05 | 163 | 125 | 5 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.70e-05 | 163 | 125 | 5 | d2fcd6f561748f7d29a051c504f016952ba32d0f | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 165 | 125 | 5 | 8a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 1.12e-04 | 168 | 125 | 5 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 1.18e-04 | 170 | 125 | 5 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-04 | 171 | 125 | 5 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.25e-04 | 172 | 125 | 5 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-04 | 173 | 125 | 5 | 07798461d12d04f3dabff03481c999cb07c5af2f | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 175 | 125 | 5 | 98dc3b6f69a29d587f503898f09912700950e3d9 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 175 | 125 | 5 | 0801cccec6915aefc135262fc74580280fd51aa5 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 175 | 125 | 5 | 09163e7030f76d706eccabdb1d5ec45f8412aa75 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 1.43e-04 | 177 | 125 | 5 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-04 | 179 | 125 | 5 | abc6797bd3884aa75dca58fcb2523ee321243ab1 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-04 | 179 | 125 | 5 | 0b996d6e881f31e6b80d359f7caac70ecdeb9982 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-04 | 179 | 125 | 5 | 1c0c0647a111f691dae55f4ed8c51006059ce020 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-04 | 179 | 125 | 5 | 9fd9b136ecbcbd4e4f0d5875ede98d8d48608afb | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 180 | 125 | 5 | 25f8e82bbc1853cb7d072484e99369c72779dd1e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 180 | 125 | 5 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 181 | 125 | 5 | bec7076efe94898213a62db72d171d737949977e | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 181 | 125 | 5 | cf149b30b814cf87c9e923ef502cadf7fe4a3597 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 182 | 125 | 5 | 4a85429d365c4b2d73fc921f261b4b7635ac40bd | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 182 | 125 | 5 | 53213af34af3337f5edc734d3b7b79e4349eac0d | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 182 | 125 | 5 | 7909089ed6325c44edd6f9b7e8b1d542398222ea | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 183 | 125 | 5 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 183 | 125 | 5 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.67e-04 | 183 | 125 | 5 | 6cbc88c27dc957d182526e84824f70c8e860bf74 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 183 | 125 | 5 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-04 | 184 | 125 | 5 | 97e97de52daaff8840f4ee76a94ba5e3f79de7ce | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.71e-04 | 184 | 125 | 5 | ce31684772e47a294155f368e50b49753f7c8e87 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.75e-04 | 185 | 125 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 1.75e-04 | 185 | 125 | 5 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.75e-04 | 185 | 125 | 5 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.80e-04 | 186 | 125 | 5 | 0cc7504297fd0c97ea50e4b3ff58fcedc4c1cfaa | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-04 | 186 | 125 | 5 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-04 | 186 | 125 | 5 | 9d250d5ae7cf9129be05b41d70cb6c3a046c5f1e | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-04 | 186 | 125 | 5 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery|Adult / Lineage, Cell type, age group and donor | 1.80e-04 | 186 | 125 | 5 | 2d1c4ea2e401db89971582ee54618a8b0c81b8ac | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.89e-04 | 188 | 125 | 5 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.89e-04 | 188 | 125 | 5 | b9c5d573fc5ab0f7f38c55d006f9576634b05462 | |
| ToppCell | Substantia_nigra-Endothelial|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.94e-04 | 189 | 125 | 5 | bef8234bd9c4d6e3cdef0791d8066b39ba56ebba | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 1.94e-04 | 189 | 125 | 5 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.94e-04 | 189 | 125 | 5 | 4bc3826e0515b3cf2e2ef72a7b2cf9c32ade1812 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.94e-04 | 189 | 125 | 5 | 1d660bceee449aebf12fc9af4c74af246837b27a | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.98e-04 | 190 | 125 | 5 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-04 | 190 | 125 | 5 | d4aefae2d3164db6a9e953c54af0151501e9d1da | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.98e-04 | 190 | 125 | 5 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.98e-04 | 190 | 125 | 5 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.03e-04 | 191 | 125 | 5 | edfd5eeff69b5de19c5df3d899e42acd7e015913 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.03e-04 | 191 | 125 | 5 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.03e-04 | 191 | 125 | 5 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature3_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.08e-04 | 192 | 125 | 5 | 7dbe3117a0f58ff2e838963d49f788a59a4351d7 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 192 | 125 | 5 | fa0ef05a32c661bdd59b5a9b6f75fd647ee937f3 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.08e-04 | 192 | 125 | 5 | f68e6cbde87678122da1b5c0061904cfb7d04bf5 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.08e-04 | 192 | 125 | 5 | b877d14be9d04ab0010e340909e3a23de92613db | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 192 | 125 | 5 | 4e63d95f75fe6eb3f817e84528883e95093c5bbd | |
| ToppCell | 15-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 2.13e-04 | 193 | 125 | 5 | 6ea0444fc3dc156997129387184e6418947f4b12 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.13e-04 | 193 | 125 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.13e-04 | 193 | 125 | 5 | 2661ad9107ed9231e4afea4442a79051139a31df | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.13e-04 | 193 | 125 | 5 | 54604c2c5dce2ff6f3ec7ca82b595b09b8cdafe8 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.13e-04 | 193 | 125 | 5 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| Drug | naringenin chalcone | 4.04e-09 | 5 | 123 | 4 | ctd:C027329 | |
| Drug | anthrarobin | 4.04e-09 | 5 | 123 | 4 | ctd:C032186 | |
| Drug | tritanol | 5.27e-09 | 13 | 123 | 5 | CID000006457 | |
| Drug | H-Ni | 7.51e-09 | 28 | 123 | 6 | CID000445665 | |
| Drug | AC1L1G0K | 8.04e-09 | 49 | 123 | 7 | CID000003473 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 1.21e-08 | 6 | 123 | 4 | ctd:C543211 | |
| Drug | alloin | 1.21e-08 | 6 | 123 | 4 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 1.21e-08 | 6 | 123 | 4 | ctd:C107497 | |
| Drug | 2',4'-dihydroxychalcone | 2.80e-08 | 7 | 123 | 4 | ctd:C059354 | |
| Drug | 1,4-dihydroxyanthraquinone | 5.58e-08 | 8 | 123 | 4 | ctd:C034890 | |
| Drug | Benzamidoxime hydrochloride | 8.05e-08 | 21 | 123 | 5 | CID000069186 | |
| Drug | AC1MRQNQ | 1.00e-07 | 9 | 123 | 4 | CID003522271 | |
| Drug | DHPASiU | 1.00e-07 | 9 | 123 | 4 | CID000197602 | |
| Drug | 3-iodophenol | 1.00e-07 | 9 | 123 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 1.00e-07 | 9 | 123 | 4 | CID000186631 | |
| Drug | Chebi:32663 | 1.00e-07 | 9 | 123 | 4 | CID005460873 | |
| Drug | androsterone glucuronide | 1.14e-07 | 43 | 123 | 6 | CID000114833 | |
| Drug | phenanthridine | 1.32e-07 | 23 | 123 | 5 | CID000009189 | |
| Drug | AS-3201 | 1.66e-07 | 24 | 123 | 5 | CID000153948 | |
| Drug | 2,6-dihydroxyanthraquinone | 1.66e-07 | 10 | 123 | 4 | ctd:C034889 | |
| Drug | Thymol | 2.55e-07 | 26 | 123 | 5 | ctd:D013943 | |
| Drug | 4-nitrophenyl)imidazole | 2.60e-07 | 11 | 123 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 2.60e-07 | 11 | 123 | 4 | CID006442661 | |
| Drug | Scopoletin | 3.11e-07 | 27 | 123 | 5 | ctd:D012603 | |
| Drug | N-OH-DABZ | 3.88e-07 | 12 | 123 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 3.88e-07 | 12 | 123 | 4 | CID000088735 | |
| Drug | 4-hydroxyestrone | 3.88e-07 | 12 | 123 | 4 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 3.88e-07 | 12 | 123 | 4 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 3.88e-07 | 12 | 123 | 4 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 3.88e-07 | 12 | 123 | 4 | CID000276709 | |
| Drug | AC1L1JAL | 4.54e-07 | 29 | 123 | 5 | CID000004954 | |
| Drug | trans-3'-hydroxycotinine | 4.54e-07 | 29 | 123 | 5 | CID000000414 | |
| Drug | HCG 004 | 4.59e-07 | 54 | 123 | 6 | CID000064928 | |
| Drug | sulfinpyrazone | 4.62e-07 | 87 | 123 | 7 | CID000005342 | |
| Drug | AC1L9E0Q | 5.42e-07 | 30 | 123 | 5 | CID000443095 | |
| Drug | dihydroartemisinin | 5.42e-07 | 30 | 123 | 5 | CID000107770 | |
| Drug | 2-hydroxyestrone | 5.58e-07 | 13 | 123 | 4 | ctd:C024980 | |
| Drug | 5-azido-UDP-glucuronic acid | 5.58e-07 | 13 | 123 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 5.58e-07 | 13 | 123 | 4 | CID000000411 | |
| Drug | alizarin | 5.58e-07 | 13 | 123 | 4 | ctd:C010078 | |
| Drug | hydratropic acid | 6.13e-07 | 4 | 123 | 3 | ctd:C013025 | |
| Drug | 2-vanillin | 6.13e-07 | 4 | 123 | 3 | ctd:C060843 | |
| Drug | diphenylacetic acid | 6.13e-07 | 4 | 123 | 3 | ctd:C037760 | |
| Drug | 4'-HPPH | 6.44e-07 | 31 | 123 | 5 | CID000017732 | |
| Drug | NNAL | 7.60e-07 | 32 | 123 | 5 | CID000104856 | |
| Drug | propranolol glucuronide | 7.79e-07 | 14 | 123 | 4 | CID000119515 | |
| Drug | PCB-61 | 7.79e-07 | 14 | 123 | 4 | CID000036401 | |
| Drug | 6-methylsalicylic acid | 8.92e-07 | 33 | 123 | 5 | CID000011279 | |
| Drug | kaempferol | 9.71e-07 | 97 | 123 | 7 | CID005280863 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 1.06e-06 | 15 | 123 | 4 | CID000040469 | |
| Drug | afloqualone | 1.06e-06 | 15 | 123 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 1.06e-06 | 15 | 123 | 4 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 1.06e-06 | 15 | 123 | 4 | CID000010752 | |
| Drug | bergamottin | 1.06e-06 | 15 | 123 | 4 | ctd:C068337 | |
| Drug | sulforaphane nitrile | 1.06e-06 | 15 | 123 | 4 | CID000543743 | |
| Drug | bevirimat | 1.40e-06 | 36 | 123 | 5 | CID000457928 | |
| Drug | quercetin-3,4'-diglucoside | 1.40e-06 | 16 | 123 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 1.40e-06 | 16 | 123 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 1.40e-06 | 16 | 123 | 4 | CID005497144 | |
| Drug | isovaleric acid | 1.53e-06 | 5 | 123 | 3 | ctd:C008216 | |
| Drug | biphenylylacetic acid | 1.53e-06 | 5 | 123 | 3 | ctd:C012776 | |
| Drug | N-Fg | 1.61e-06 | 37 | 123 | 5 | CID000445227 | |
| Drug | Phloretin | 1.61e-06 | 37 | 123 | 5 | ctd:D010693 | |
| Drug | AC1MRGT8 | 1.68e-06 | 67 | 123 | 6 | CID003517815 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 1.83e-06 | 17 | 123 | 4 | CID000003573 | |
| Drug | 6-hydroxychrysene | 1.83e-06 | 17 | 123 | 4 | CID000037766 | |
| Drug | formononetin | 1.85e-06 | 38 | 123 | 5 | ctd:C007768 | |
| Drug | 4-methylumbelliferyl glucuronide | 1.85e-06 | 38 | 123 | 5 | CID000091553 | |
| Drug | acacetin | 1.85e-06 | 38 | 123 | 5 | CID005280442 | |
| Drug | SureCN12722713 | 2.34e-06 | 18 | 123 | 4 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 2.34e-06 | 18 | 123 | 4 | CID000152226 | |
| Drug | Br 2 | 2.34e-06 | 18 | 123 | 4 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 2.34e-06 | 18 | 123 | 4 | CID000036614 | |
| Drug | ApApG | 2.34e-06 | 18 | 123 | 4 | CID003081975 | |
| Drug | C1 11-32 | 2.34e-06 | 18 | 123 | 4 | CID000443077 | |
| Drug | C11131 | 2.34e-06 | 18 | 123 | 4 | CID000443076 | |
| Drug | harmol | 2.40e-06 | 40 | 123 | 5 | CID000068094 | |
| Drug | erythromycin stearate | 2.41e-06 | 111 | 123 | 7 | CID000012559 | |
| Drug | hydroxyl radicals | ABCC1 ASRGL1 ATP7A CYP26B1 PDK2 AOX1 SLC26A9 DNM1L GCDH NDUFS1 MRPS22 INPP4B FASN ATP2C1 GUCY2C TREH AGA UCKL1 HADHB UQCRH CDC27 GFM1 | 2.75e-06 | 1341 | 123 | 22 | CID000000961 |
| Drug | 9-OH-risperidone | 2.95e-06 | 19 | 123 | 4 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 2.95e-06 | 19 | 123 | 4 | CID000091433 | |
| Drug | almokalant | 2.95e-06 | 19 | 123 | 4 | CID003033962 | |
| Drug | 3-phenylpropionic acid | 3.04e-06 | 6 | 123 | 3 | ctd:C035253 | |
| Drug | Indoprofen | 3.04e-06 | 6 | 123 | 3 | ctd:D007216 | |
| Drug | 7,8-benzoquinoline | 3.46e-06 | 43 | 123 | 5 | CID000009191 | |
| Drug | tectochrysin | 3.67e-06 | 20 | 123 | 4 | CID005281954 | |
| Drug | AC1L1OBF | 3.67e-06 | 20 | 123 | 4 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 3.67e-06 | 20 | 123 | 4 | CID000116545 | |
| Drug | entacapone | 3.67e-06 | 20 | 123 | 4 | ctd:C071192 | |
| Drug | 4-nitrophenol | 4.36e-06 | 45 | 123 | 5 | ctd:C024836 | |
| Drug | Eugenol | ABCC1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 ARHGAP17 F13A1 ARL4C FASN | 4.39e-06 | 229 | 123 | 9 | ctd:D005054 |
| Drug | estriol-16-glucuronide | 4.52e-06 | 21 | 123 | 4 | CID000122281 | |
| Drug | dulcin | 4.52e-06 | 21 | 123 | 4 | CID000009013 | |
| Drug | 7,3'-dihydroxy-4'-methoxyisoflavone | 4.87e-06 | 46 | 123 | 5 | ctd:C121707 | |
| Drug | acridine | 5.13e-06 | 81 | 123 | 6 | CID000009215 | |
| Drug | grepafloxacin | 5.30e-06 | 7 | 123 | 3 | ctd:C075375 | |
| Drug | amonafide | 5.50e-06 | 22 | 123 | 4 | CID000050515 | |
| Drug | N-methylpiperazine | 5.50e-06 | 22 | 123 | 4 | CID000053167 | |
| Drug | plumbagin | 5.50e-06 | 22 | 123 | 4 | ctd:C014758 | |
| Drug | retigabine | 6.03e-06 | 48 | 123 | 5 | CID000121892 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 1.39e-09 | 5 | 122 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 1.39e-09 | 5 | 122 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 1.39e-09 | 5 | 122 | 4 | EFO_0801853 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 6.62e-09 | 17 | 122 | 5 | EFO_0004611, EFO_0007800 | |
| Disease | X-21339 measurement | 9.64e-09 | 7 | 122 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 1.92e-08 | 8 | 122 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.92e-08 | 8 | 122 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 1.92e-08 | 8 | 122 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.92e-08 | 8 | 122 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 1.92e-08 | 8 | 122 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 1.92e-08 | 8 | 122 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.92e-08 | 8 | 122 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 1.92e-08 | 8 | 122 | 4 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 1.92e-08 | 8 | 122 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 1.92e-08 | 8 | 122 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.92e-08 | 8 | 122 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 1.92e-08 | 8 | 122 | 4 | EFO_0800766 | |
| Disease | X-11442 measurement | 3.45e-08 | 9 | 122 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 3.45e-08 | 9 | 122 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 3.45e-08 | 9 | 122 | 4 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 3.45e-08 | 9 | 122 | 4 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 3.45e-08 | 9 | 122 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 3.45e-08 | 9 | 122 | 4 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 3.45e-08 | 9 | 122 | 4 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 3.45e-08 | 9 | 122 | 4 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 3.45e-08 | 9 | 122 | 4 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 5.73e-08 | 10 | 122 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 5.73e-08 | 10 | 122 | 4 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 5.73e-08 | 10 | 122 | 4 | EFO_0802185 | |
| Disease | X-23974 measurement | 5.73e-08 | 10 | 122 | 4 | EFO_0800867 | |
| Disease | indole-3-carboxylate measurement | 6.90e-08 | 3 | 122 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 6.90e-08 | 3 | 122 | 3 | EFO_0022216 | |
| Disease | pregnenetriol sulfate measurement | 8.98e-08 | 11 | 122 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 8.98e-08 | 11 | 122 | 4 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 8.98e-08 | 11 | 122 | 4 | EFO_0800972 | |
| Disease | X-21796 measurement | 8.98e-08 | 11 | 122 | 4 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 8.98e-08 | 11 | 122 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 8.98e-08 | 11 | 122 | 4 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 1.34e-07 | 12 | 122 | 4 | EFO_0800079 | |
| Disease | biliverdin measurement | 1.34e-07 | 12 | 122 | 4 | EFO_0021033 | |
| Disease | pregnenetriol disulfate measurement | 1.93e-07 | 13 | 122 | 4 | EFO_0800587 | |
| Disease | retinol dehydrogenase 16 measurement | 1.93e-07 | 13 | 122 | 4 | EFO_0802007 | |
| Disease | serum metabolite measurement | ABCC1 ASRGL1 CYP26B1 CETP UGT1A10 UGT1A8 UGT1A7 UGT1A9 GCDH LAMC3 F13A1 TREH AGA TLN2 CCDC180 IL33 PPP6R3 | 3.73e-07 | 945 | 122 | 17 | EFO_0005653 |
| Disease | X-21441 measurement | 6.35e-07 | 17 | 122 | 4 | EFO_0800814 | |
| Disease | angiopoietin-related protein 1 measurement | 8.14e-07 | 18 | 122 | 4 | EFO_0801382 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 1.37e-06 | 6 | 122 | 3 | EFO_0800566 | |
| Disease | tissue factor measurement | 1.58e-06 | 21 | 122 | 4 | EFO_0010623 | |
| Disease | neuroblastoma, cutaneous melanoma | 5.27e-06 | 28 | 122 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | xanthurenate measurement | 6.10e-06 | 29 | 122 | 4 | EFO_0010551 | |
| Disease | response to dolutegravir | 7.01e-06 | 30 | 122 | 4 | EFO_0600017 | |
| Disease | indoleacetate measurement | 8.10e-06 | 10 | 122 | 3 | EFO_0021015 | |
| Disease | vitamin D deficiency | 1.65e-05 | 37 | 122 | 4 | EFO_0003762 | |
| Disease | X-24588 measurement | 1.91e-05 | 13 | 122 | 3 | EFO_0800898 | |
| Disease | hormone measurement | 2.65e-05 | 84 | 122 | 5 | EFO_0004730 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 3.47e-05 | 147 | 122 | 6 | DOID:9352 (biomarker_via_orthology) | |
| Disease | vitamin D measurement, COVID-19 | 5.10e-05 | 49 | 122 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | urate measurement, spine bone mineral density | 9.93e-05 | 58 | 122 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | Hypertrophic obstructive cardiomyopathy | 1.48e-04 | 25 | 122 | 3 | C4551472 | |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 2.18e-04 | 71 | 122 | 4 | EFO_0004735, EFO_0007965 | |
| Disease | platelet measurement | 3.47e-04 | 315 | 122 | 7 | EFO_0005036 | |
| Disease | thyroxine measurement | 3.97e-04 | 83 | 122 | 4 | EFO_0005130 | |
| Disease | cholelithiasis | 4.96e-04 | 88 | 122 | 4 | EFO_0004799 | |
| Disease | bilirubin measurement | 5.18e-04 | 442 | 122 | 8 | EFO_0004570 | |
| Disease | Inherited neuropathies | 6.09e-04 | 40 | 122 | 3 | C0598589 | |
| Disease | gallstones | 1.07e-03 | 108 | 122 | 4 | EFO_0004210 | |
| Disease | dodecanedioate measurement | 1.09e-03 | 12 | 122 | 2 | EFO_0021054 | |
| Disease | coagulation factor X measurement | 1.28e-03 | 13 | 122 | 2 | EFO_0020265 | |
| Disease | glutaroyl carnitine measurement | 1.28e-03 | 13 | 122 | 2 | EFO_0021005 | |
| Disease | inositol measurement | 1.49e-03 | 14 | 122 | 2 | EFO_0010504 | |
| Disease | Hypertrophic Cardiomyopathy | 1.71e-03 | 57 | 122 | 3 | C0007194 | |
| Disease | HSV2 virologic severity measurement | 1.72e-03 | 15 | 122 | 2 | EFO_0009010 | |
| Disease | glycerate measurement | 1.72e-03 | 15 | 122 | 2 | EFO_0021029 | |
| Disease | triacylglycerol 50:5 measurement | 1.96e-03 | 16 | 122 | 2 | EFO_0010412 | |
| Disease | glutarylcarnitine (C5-DC) measurement | 2.21e-03 | 17 | 122 | 2 | EFO_0800030 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 2.21e-03 | 17 | 122 | 2 | cv:C0270914 | |
| Disease | metabolite measurement | 2.33e-03 | 560 | 122 | 8 | EFO_0004725 | |
| Disease | Osteochondrodysplasias | 2.77e-03 | 19 | 122 | 2 | C0029422 | |
| Disease | acute lymphoblastic leukemia, response to antineoplastic agent | 2.77e-03 | 19 | 122 | 2 | EFO_0000220, GO_0097327 | |
| Disease | vitamin D measurement | 2.79e-03 | 336 | 122 | 6 | EFO_0004631 | |
| Disease | hip circumference | 2.87e-03 | 338 | 122 | 6 | EFO_0005093 | |
| Disease | susceptibility to mononucleosis measurement | 2.96e-03 | 69 | 122 | 3 | EFO_0008403 | |
| Disease | seborrheic dermatitis | 3.07e-03 | 20 | 122 | 2 | EFO_1000764 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.14e-03 | 145 | 122 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | triacylglycerol 48:2 measurement | 3.71e-03 | 22 | 122 | 2 | EFO_0010405 | |
| Disease | phosphatidylcholine 34:3 measurement | 3.71e-03 | 22 | 122 | 2 | EFO_0010377 | |
| Disease | cortical surface area measurement | RABEP2 KIF1B HIPK2 LAMC3 ACTN4 DYSF TFDP2 ARL4C TREH ERC2 SYT4 TLN2 SMG6 | 3.80e-03 | 1345 | 122 | 13 | EFO_0010736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SVEGDGAMMEEGVKS | 421 | Q15361 | |
| DTMGKEMGSQEGTRL | 1161 | Q86US8 | |
| VIDDTIEMETGLKAM | 891 | A6H8Y1 | |
| MLSLMGDEFKAVLET | 301 | P11597 | |
| TDGLNALLGKDMMSD | 666 | Q92556 | |
| EGLTEGMDKLYEMIL | 166 | P56559 | |
| KLLGDGDLMMTSFER | 1571 | Q6UB99 | |
| KLDLMDAGTDAMDVL | 216 | O00429 | |
| KMMGNGVLLSEDDTI | 1206 | Q96Q42 | |
| LLVTDMQGVGMKLTD | 2076 | Q86TB3 | |
| EMDASIMDGKDLSAG | 76 | Q7L266 | |
| IVVKEMDAGGDMIAV | 11 | Q8TAX9 | |
| GSKIMQLTAMDADEG | 1756 | Q6V0I7 | |
| AEEIVDGNAKMTLGM | 131 | O43707 | |
| GKTDMERIGLFSEME | 6 | A7E2U8 | |
| LVKDMSTVQMGEGLE | 756 | Q99490 | |
| AGASMMEIKELIESE | 311 | Q9ULG3 | |
| MDESKEGSIQGLEEM | 726 | Q9P1Z9 | |
| GESGLTQLLMTEVMK | 111 | Q9H257 | |
| VGMEGGIVLSVESMK | 181 | Q96EU7 | |
| GISEGMEMKVALSTT | 741 | Q9UKL3 | |
| LTDGASAMLIMAEEK | 311 | P55084 | |
| TEGALIALAMKMGLD | 426 | P98194 | |
| LDAMTLIKEDMSIFG | 56 | Q5T6C5 | |
| DESLFVIEMGLLKMD | 881 | Q06278 | |
| MGLEVVLMTGDNSKT | 1246 | Q04656 | |
| EREAMKSSELMLELG | 681 | P15918 | |
| MGLEDEQKMLTESGD | 1 | A0A096LP55 | |
| MGLEDEQKMLTESGD | 1 | P07919 | |
| ELAGALAEMETMKAV | 46 | Q9H5N1 | |
| IDIAKMALEILSFMG | 891 | P25092 | |
| LTTKIMEEGMGQTIS | 216 | Q9Y4X5 | |
| MTTDLEGSDMLVEKA | 481 | Q9H2X6 | |
| DQLGKSIIGMMEFSL | 1486 | Q2M2H8 | |
| GQVATLSKLLEMMEE | 656 | Q9C0I1 | |
| ALEMEDGLNKTMTII | 721 | Q13201 | |
| STLLDGKMVMEGFSE | 1091 | O60333 | |
| TTEGDLKVEMMAGGT | 21 | Q68D85 | |
| MTMQELKDGTLELIF | 281 | Q9NR63 | |
| IGMLEDMAVGISDLK | 676 | O15327 | |
| RLILLELMSGGDMKS | 586 | P29376 | |
| LDLMGSGKESLIFMK | 241 | Q3V5L5 | |
| IGSMGEALEEELDSM | 216 | Q16342 | |
| ALLLGLMMVVTGDED | 11 | Q96S96 | |
| MASKITDMQLGGSVE | 916 | Q12986 | |
| VTKQIGGDGMMDITD | 466 | P00488 | |
| IKNEMATSEAVMGLG | 411 | P47870 | |
| MALGLGLMVKSIEGD | 171 | Q96FB5 | |
| GTLAGEIRDMKDMLE | 521 | O15083 | |
| MIDDLLGVKTSMGDR | 391 | Q96M63 | |
| MVKLLDDGTFMIPGE | 81 | Q96JZ2 | |
| LMEMSKDSLLGDKGQ | 636 | P33993 | |
| MVALGEEDLSIKMSD | 276 | Q15119 | |
| MDNSMGTEEITVLKG | 3436 | Q96RW7 | |
| DSEIMVMLGENGTGK | 371 | P61221 | |
| VTKAMGMDVLNEAIG | 301 | O95704 | |
| VLAVDKDMGSAGMVV | 146 | Q9BYE9 | |
| NESGDGVDGKMLMVT | 171 | O95760 | |
| VRMMGEIVSALEGKI | 391 | P41002 | |
| LRASATGMIIMDGVE | 256 | Q92947 | |
| MAAILGDTIMVAKGL | 1 | Q8NI60 | |
| ELGETTLDAMIMDGT | 81 | P20933 | |
| IMDGTTMDVGAVGDL | 91 | P20933 | |
| RIDVMGGSEEEFMKI | 721 | Q7Z4H7 | |
| LSGKMMVGEIQETRL | 96 | A0ZSE6 | |
| TKMGGLEEDTEIMDN | 5706 | Q8NDH2 | |
| ESGLLDGVMMTDAAL | 311 | Q13003 | |
| MEEVVIAGMSGKLPE | 1 | P49327 | |
| AEMMVKVVALGLLSG | 1341 | O95180 | |
| EKLVSAMISAEGEVM | 1611 | Q8IVF4 | |
| EMELKLERAGMLVSG | 3271 | Q9P225 | |
| GKDGVGAVMDSMELE | 81 | Q96RP9 | |
| MDTKGLMKAVGEEAL | 336 | O43304 | |
| ELTMGKGQASAMELL | 316 | Q4U2R8 | |
| KAAAEGLMSLLREMG | 456 | P30260 | |
| LGGVMDDKSEDSMSV | 1116 | O75923 | |
| TDDTLMEESGKMIFL | 451 | Q2NKX8 | |
| FTGVESGVLMLMALD | 116 | Q8NH56 | |
| ALGEKTEITGAMTMT | 466 | Q12889 | |
| MVAGMLGLREEKSED | 1 | P51608 | |
| DVIIVMSGGKISEMG | 836 | P33527 | |
| MGISLEMSGIKVGDD | 431 | Q9H1H9 | |
| MDEEVQSILTKMTGL | 71 | P82650 | |
| LSGIELSEGKMLMNR | 261 | Q9H2B2 | |
| LMQASKGLSDLEIGM | 906 | Q14C87 | |
| ILDMSGVSFVDLMGI | 666 | Q7LBE3 | |
| EKMFMSELSGNIIDI | 211 | P28331 | |
| ACVMLLLETGMKEEG | 271 | Q68EM7 | |
| TAEVMMGILRDKESG | 261 | Q96FV2 | |
| DGEMIEGKLATLMST | 161 | Q8WTS6 | |
| DIEVLKRMGMSFGLE | 311 | Q14188 | |
| GELEEKTAGMMTSAE | 1151 | Q9Y2K9 | |
| EGTISMAEGEDLSLM | 556 | Q15642 | |
| LQSMVDELMVKKSGG | 376 | Q15036 | |
| GMTGMAGSLLEDLKQ | 1721 | Q86UP3 | |
| ELMPKLKELGATMDG | 736 | Q12768 | |
| TMEQLEAMTGGEQLK | 696 | Q8NI27 | |
| METKGAGVTLNVLEM | 401 | Q9HAW8 | |
| MMGAVLIGETDLEET | 456 | Q8WU10 | |
| SLLSVRMGKEEELLM | 2026 | Q15413 | |
| VMENSKVLGEAMTGI | 1396 | Q9Y490 | |
| MEGLLLSEMAETVKG | 181 | O43280 | |
| RESSGDGMKMEGLLN | 761 | O15014 | |
| SGQILMEFETMKLED | 501 | Q8IZ13 | |
| IMGLEGEDEGAISML | 361 | Q8WVM8 | |
| EMKQAIELVESGGMG | 581 | P19634 | |
| TIKTMLEDLGMDDEG | 26 | P63208 | |
| MQKLGEGEGSMTKEE | 106 | Q9Y5X3 | |
| METKGAGVTLNVLEM | 401 | O60656 | |
| MKLDKDGMAGLTGII | 361 | Q8NDW8 | |
| ALEEMGKSEMLVAVA | 926 | Q8IZJ1 | |
| DMVALTGEKVDILVM | 661 | Q9BZ71 | |
| LEATAMGTEKGAVLM | 131 | Q8TAG6 | |
| GGMVDAIAEAMSKLD | 1826 | Q9Y4G6 | |
| EDKIFLLSLLMAEMG | 476 | Q9NWZ5 | |
| IAVGMAMDLVLDDSK | 116 | P10827 | |
| VSLMVLLAVDVEGMK | 636 | Q13395 | |
| IGMLIESMAGKSAAL | 926 | Q9H9Y6 | |
| ETVMNGGMKETLSLT | 791 | Q5H9R7 | |
| EMKMLLSGILGAVVT | 121 | Q6ZQQ6 | |
| LDLFKLTIGMGDLEM | 671 | Q9HBA0 | |
| METKGAGVTLNVLEM | 401 | Q9HAW7 | |
| EIVKMVMISLEGEDG | 206 | P13010 | |
| DDMGLGKTLTMIALI | 596 | Q9UNY4 | |
| METKGAGVTLNVLEM | 401 | Q9HAW9 | |
| TVMGARTLLADLEGM | 1331 | Q9Y6N6 | |
| VKTSLLDNMIGVGDM | 6 | O43795 | |
| TVLLTGMEGIQMDEE | 256 | Q13287 |